TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy-Reference-Cited by-同舟云学术

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

Published:2016-04-22 Issue:1 Volume:4 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Munch-Petersen Helga D.,Asmar Fazila,Dimopoulos Konstantinos,Areškevičiūtė Aušrinė,Brown Peter,Girkov Mia Seremet,Pedersen Anja,Sjö Lene D.,Heegaard Steffen,Broholm Helle,Kristensen Lasse S.,Ralfkiaer Elisabeth,Grønbæk Kirsten

Funder

Rigshospitalet Forskningspuljer (DK)

Kræftens Bekæmpelse

Det Frie Forskningsråd

Novo Nordisk

Dagmar Marshalls Fond

Christian Andersens Grant

Dansk Kræftforsknings Fond

Agnes og Poul Friis Fond

Einar Willumsen Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-016-0307-6

Reference54 articles.

1. Adachi J-I, Mishima K, Wakiya K, Suzuki T, Fukuoka K, Yanagisawa T, Matsutani M, Sasaki A, Nishikawa R. O6-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment. J Neurooncol. 2012;107:147–53. doi: 10.1007/s11060-011-0721-3 .

2. Akbari M, Hansen MD, Halgunset J, Skorpen F, Krokan HE. Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner. J Mol Diagn. 2005;7:36–9.

3. Arai M, Sasaki A, Saito N, Nakazato Y. Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system. Pathol Int. 2005;55:122–9. doi: 10.1111/j.1440-1827.2005.01808.x .

4. Asmar F, Hother C, Kulosman G, Treppendahl MB, Nielsen HM, Ralfkiaer U, Pedersen A, Møller MB, Ralfkiaer E, de Nully Brown P, Grønbæk K. Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome? Oncotarget. 2014;5:1912–25.

5. Bullock AN, Henckel J, Fersht AR. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy. Oncogene. 2000;19:1245–56. doi: 10.1038/sj.onc.1203434 .

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Mutational Hotspots on Cancer Survival;Cancers;2024-03-06

2. Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets;Modern Pathology;2023-12

3. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study;Annals of Hematology;2023-06-08

4. Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma;World Neurosurgery;2023-02

5. Elevated expression of transforming acidic coiled‐coil‐containing protein 3 (TACC3) reflects aggressiveness of primary central nervous system lymphomas;Pathology International;2022-08-12